glp 1 and kidney transplant Glp-1 receptor agonists: A boon for recipients? GLP-1, Weight Loss & Kidney

The results of a recent national study conducted by the Arkansas Agricultural Experiment Station found that these weight loss drugs known as Glucagon-like peptide-1 agonists or GLP-1s lead to new food and drink consumption patterns, which underscore observed changes in food and beverage marketing

The median rolling surgical volume for centers was 12 surgeries in the past year (IQR 7, 18)

After two weeks, Aetna approves it

The primary endpoint is the time to the first occurrence of a composite primary outcome event, defined as a persistent eGFR decline (50% from baseline), reaching ESRD, renal death, or CV death

Due to the studys design, small sample size, variation in dosing and variable results, the findings of this study are preliminary and highlight the need for further research